The First Affiliated Hospital of Guangzhou Medical University: Phase 4 study in Pneumococcal Polysaccharide Vaccine, Influenza Vaccines (1278 participants)
The First Affiliated Hospital of Guangzhou Medical University: Phase 4 study in Pneumococcal Polysaccharide Vaccine, Influenza Vaccines (1278 participants). Its enrollment of 1,278 is top-decile (95th percentile of 9,177 records). Dated 15 days ago, it is in the active follow-up window. Score 40/100. As of 2026-11-05, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 1,278 · 95th percentile of 9,177 ClinicalTrialStartPulse records · 16.0x the median
Free preview: all 13 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | The First Affiliated Hospital of Guangzhou Medical University |
| Sponsor type | Academic and hospital |
| Study | Preoperative Pneumococcal and Influenza Vaccination to Prevent Postoperative Pulmonary Infection in Patients Undergoing Lung Resection for Pulmonary Nodules or Lung Cancer |
| NCT ID | NCT07885540 |
| Phase | Phase 4 |
| Status | not yet recruiting |
| Conditions | Pneumococcal Polysaccharide Vaccine; Influenza Vaccines; Preoperative; Lung Resection Surgery; Thoracic Surgery |
| Intervention types | biological |
| Target enrollment | 1278 |
| Posted | 2026-10-21 |
| Planned start | 2026-11-01 |
| Event | Newly registered study |
| Event date | 2026-10-21 |
| enrollment percentile | 95th of 9,177 (median 80, 16.0x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch The First Affiliated Hospital of Guangzhou Medical University
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock The First Affiliated Hospital of Guangzhou Medical University + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-21
- Data refreshed: 2026-11-05
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Thu, 05 Nov 2026 08:46:16 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: The First Affiliated Hospital of Guangzhou Medical University and 6,823 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,823
- The First Affiliated Hospital of Guangzhou Medical University's enrollment: 95th percentile of 9,177 records
- Timing: Medium: dated in the last 30 days
- Estimated pipeline if you contact every NONUS peer: $1,364,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
40 / 100 Score
- 1278 participants planned.
- Not yet recruiting: vendors still being chosen.
What is the ClinicalTrialStartPulse record for The First Affiliated Hospital of Guangzhou Medical University?
The First Affiliated Hospital of Guangzhou Medical University registered a Phase 4 study (NCT07885540) in Pneumococcal Polysaccharide Vaccine targeting 1278 participants, posted 2026-10-21.
How does The First Affiliated Hospital of Guangzhou Medical University compare to other ClinicalTrialStartPulse records?
This is a top-decile record: its enrollment of 1,278 is 16.0x the median of 80 across 9,177 records. It is 15 days old, still within a typical 45-day follow-up window.
The First Affiliated Hospital of Guangzhou Medical University vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| The First Affiliated Hospital of Guangzhou Medical University | NONUS | 1,278 | 95th | 2026-10-21 |
| AstraZeneca | NONUS | 731 | 92nd | 2026-10-30 |
| GlaxoSmithKline | NONUS | 303 | 83rd | 2026-11-02 |
| Viatris Inc. | NONUS | 100 | 60th | 2026-11-03 |
Related records
ClinicalTrialStartPulse: Phase 4 ClinicalTrialStartPulse: Outside the US only
How to monitor The First Affiliated Hospital of Guangzhou Medical University and peer phase 4 records
Get new ClinicalTrialStartPulse records like The First Affiliated Hospital of Guangzhou Medical University by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.